Form D · Biotechnology
Axcella Health Inc.
Cambridge, MA · CIK 0001633070
Offering snapshot reported Sep 23, 2022 · SEC filing
- Reported sold
- $6M Offering amount: $12M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 20, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 23, 2022 | Initial | $6,000,000 | No comparison | 2 | SEC filing |
| Feb 24, 2017 | Amendment | $42,499,998 | $0vs Feb 24, 2016 | 1 | SEC filing |
| Feb 24, 2016 | Amendment | $44,317,970 | $5,000,003vs Sep 15, 2015 | 12 | SEC filing |
| Feb 24, 2016 | Initial | $42,499,998 | No comparison | 1 | SEC filing |
| Sep 15, 2015 | Amendment | $39,317,967 | $0vs May 28, 2015 | 11 | SEC filing |
| May 28, 2015 | Amendment | $39,317,967 | $11,017,974vs Feb 17, 2015 | 11 | SEC filing |
| Feb 17, 2015 | Initial | $28,299,993 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-459774
Source: Form D, filed Sep 23, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Noubar Afeyan | Director |
| William D. Baird | Director |
| Gregory Behar | Director |
| David Berry | Director |
| Robert Connelly | Director, Executive |
| Charles Cooney | Director |
| Robert Crane | Executive |
| Virginia Dean | Executive |
| David R. Epstein | Director |
| Paul Fehlner | Executive |
| Martin Hendrix | Director |
| William Hinshaw | Director, Executive |
| Stephen Hoge | Director |
| Peter Barton Hutt | Director |
| Margaret Koziel | Executive |
| John Mendlein | Director |
| Garry Menzel | Executive |
| Jeff Moore | Executive |
| Glenn Nedwin | Director |
| Gary Pisano | Director |
| Cristina M. Rondinone | Director |
| Michael Rosenblatt | Director |
| Paul Sekhri | Director |
| Catherine A. Sohn | Director |
| Chris Viehbacher | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
840 Memorial Drive
Cambridge, MA, 02139
Cambridge, MA, 02139